Sign in
8-K

Current Report

Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-22-020460

Shareholder vote results

  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading rare-20220624.htm…